Skip to main content Skip to navigation

Case Studies

Please browse these pages to find out more about successful spin-out companies and licensing deals negotiated by Warwick Ventures on behalf of the University of Warwick.

Select tags to filter on

Rapid discovery of natural product medicines and agrochemicals

Erebagen has developed a platform that enables it to engineer soil bacteria to produce new bioactive natural products with hit-rates 20x-better than synthetic chemicals currently being used in industrial screens.

For further details, download the case study.

Wed 01 Apr 2020, 14:20 | Tags: Chemistry

ECG based low-level glucose detection

A new technology for detecting low glucose levels via ECG using a non-invasive wearable sensor, which with the latest Artificial Intelligence can detect hypoglycaemic events from raw ECG signals has been made by researchers from the University of Warwick.

For more details, download the case study

To read the press release, please click here

Mon 20 Jan 2020, 14:25 | Tags: Medicine, Diagnostics

Cytecom - portable bacteria detection device offers faster diagnostics

A discovery by researchers at the University of Warwick School of Life Sciences offers a new technology for detecting bacteria in minutes instead of waiting for lab-test results which can take days. Delays in detection can cause significant damage; infections can become life threatening very quickly if not identified and treated with appropriate antibiotics. For example, 8% of people with the severe blood infection sepsis will die for every hour of delay in proper treatment.

For more details, download the case study

Fri 26 Jul 2019, 09:30 | Tags: Medicine, Diagnostics

Medherant – innovative transdermal drug delivery moves to the next stage

Medherant has completed two Phase I clinical studies with its novel transdermal drug delivery technology, the TEPI Patch®. There is considerable interest in the transdermal delivery of drugs to overcome some of the disadvantages of oral administration, such as spikes in drug levels that can lead to side effects, and poor compliance. Patches are also a more convenient way to deliver drugs through the skin than gels and creams and provide better dose control.

For further details, download the case study

Wed 24 Jul 2019, 09:00 | Tags: Medicine

Verdel Instruments – 2D MS technology up to 10x quicker than current methods

Verdel Instruments has developed the first benchtop instrument with two dimensional mass spectrometry (2DMS) capability. It delivers rapid high quality structural analysis and sequencing of every component in a complex mixture, making pharmaceutical research and food safety testing more accurate, more efficient, and up to 10 times quicker than current mass spectrometry approaches. Verdel’s instrument is compatible with any mass spectrometer that uses linear ion trap technology.

For more details, download the case study

Wed 17 Jul 2019, 10:00 | Tags: Chemistry, Analysis, Laboratory

Q-Eye Sensors – high-speed, ultra-sensitive Terahertz sensing platform for security screening and medical imaging

Terahertz (THz) frequency radiation is a solution for the growing $500bn market for faster, more sensitive and more accurate medical imaging, security screening and product safety inspection. It is intrinsically safe, non-ionising and non-destructive. It can be used for high speed imaging and to probe spectroscopic signatures of explosives and other materials, even when hidden or in degraded visual environments. It can be used for stand-off, covert detection in personnel and crowd screening. Q-Eye Sensors is developing a THz sensing and imaging platform that enables inspection and screening devices that are orders of magnitude faster than those currently available, with a sensitivity that can detect a single photon and even see round corners.

For further details, download the case study

Tue 02 Jul 2019, 11:30 | Tags: Medicine, Security

Stoli Catalysts - cutting fine chemical manufacturing costs in half

Stoli Catalysts has developed a transformative catalysis technology that will enable the £600 billion Fine Chemicals industry to convert from batch to continuous flow, thereby potentially halving its production costs.

The platform technology of catalyst-coated tube reactors has the potential to revolutionise the market allowing for safer, lower pressure and more efficient manufacturing of perfumes, vitamins, food supplements, pharmaceuticals and other specialist applications in a more cost-effective way.

For further details, download the case study

Fri 21 Jun 2019, 12:30 | Tags: Chemistry

Interface Polymers - transforming polymers and revolutionising recycling

Polyolefins such as polyethylene and polypropylene pervade all aspects of modern life, but they have low affinity for paints, adhesives and coatings, while polyolefin composites have an inability to successfully blend in components such as fibres and particulate fillers. Due to this lack of compatibility, plastic waste comprising polyolefins mixed with other plastics has severely compromised mechanical properties so that the majority of mixed plastic waste is being incinerated or dumped instead of being reused.

Interface Polymers has developed additive technology which can improve the cost and performance characteristics of polyolefins, and also create a new type of recyclable polymer packaging.

For more details, download the case study

Tue 04 Jun 2019, 09:30 | Tags: Additives, Plastics

Humane Technologies - affordable bio-discovery technology for citizen scientists

Humane Technologies has developed innovative and affordable laboratory equipment for life sciences researchers and citizen scientists. Its products are based on accessible technologies such as 3D printing and programmable microprocessors. They are made available as blueprints for self-construction, as do-it-yourself kits, or as ready-to-use devices, expanding access to the tools and technologies which are currently found only within fully-equipped research labs.

For further details, download the case study

Fri 24 May 2019, 10:30 | Tags: Chemistry, Analysis, Laboratory

Spectra Analytics - building the world's first AI factory

Spectra Analytics is an Artificial Intelligence (AI) software firm. They are building the world’s first ‘AI Factory’, with a conveyor belt of new AI based products. The factory is built upon their scalable AI platform that allows them to rapidly develop, deploy and manage AI products. These new AI products are being developed in collaboration with their partners – businesses with expert domain knowledge and established market presence – who are delivering them to market.

This disruptive new business model allows them access deep-domain knowledge, develop AI products with an identified market, sell to an existing customer base, and scale their business through revenue shares in a diversified range of products. It benefits their partners by de-risking the AI development and providing access to a world class AI team.

For more details, download the case study

Thu 16 May 2019, 11:00 | Tags: AI

Latest news Newer news Older news